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ABSTRACT
The study objectives were to: 1) examine how calves of divergent immune status respond to BRSV
vaccination at 3 weeks of age; 2) trace glycoprotein E negative BoHV-1 antibodies from vaccinated
dams to calf sera and to investigate how passive transfer affects response to live BoHV-1 vaccine at 6
weeks of age; 3) explore the impact of passive transfer status on blood metabolites around weaning.
Thirty seven Holstein cows and their calves were included in the study. All cows were immunised with
a commercial marker vaccine against BoHV-1(gE-) administered intra-muscularly at 4 month prior to
the start of calving. Calves were assigned to 1 of 2 colostrum treatment groups: 1) 5% of BW in
colostrum fed at birth, or 2) 10% of BW in colostrum fed at birth. Calves were also immunised at 3
weeks of age with a respiratory commercial vaccine, and a booster administered 4 weeks later. Calves
were also immunised against BoHV-1 at 6 weeks of age, using one dose of a live commercial vaccine.
The results demonstrated that level of passive immunity had no effect on immune response to
vaccination and the importance of feeding colostrum from vaccinated BoHV-1 gE- dams to provide
calves with passive protection against IBRV.
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Bovine respiratory disease (BRD) is a common illness in young
calves and it has been documented that calves which have suf-
fered this illness also experience reduced growth, and the mor-
tality rate is increased (Windeyer et al., 2015). A Canadian study
carried out across 17 dairy herds reported the risk of pneumonia
to be as high as 39%, with a reoccurrence risk of 56% and the
median age of this first occurring was at 27 days of age (Van
Donkersgoed et al. 1993). Mortality cases as a result of pneumo-
nia are most common during the pre-weaning period and
shortly after weaning. It is thought that weaning, painful pro-
cedures, housing and ventilation can all be factors associated
with an increase in disease at this stage of a calf’s life (Lorenz,
Earley, et al. 2011).
Calves primarily depend on maternal colostrum after birth as
a source of protection against disease. It is the maternal derived
antibodies (MDA) from their dam which are transferred in the
colostrum that activates and regulates the innate response to
combat infection (Chase et al. 2008). However, although colos-
trum is required to protect the calf in the early stages of life
before they develop their own immunity, there may be interfer-
ence from the MDA inhibiting the calf’s ability to mount an
immune response to antigens from vaccination or natural infec-
tion (Morein et al. 2002). Fulton et al. (2004) reported that most
MDA have a decay half-life of 16–28 days, although the duration
of this immunity is dependent on the mass of antibodies
ingested and absorbed by the calf in the first 24 hours of life.
There are reports in the literature that the prolonged survival
of passively acquired immunity in calves that receive maternal
colostrum at birth is extremely inconsistent (Menanteau-Horta
et al. 1985, van der Poel et al. 1999, Kirkpatrick et al. 2008). It
is during the phase of decaying MDA that the calf is presented
with a window of susceptibility to pathogens, the calf is vulner-
able to infectious diseases mainly because the MDA or
endogenous antibodies are not at a significant level to
prevent the infection (Morein et al., 2002; Niewiesk, 2014). It
has been confirmed by several researchers that vaccinating
calves when MDA are still present can activate T-cells (Endsley
et al. 2003, Niewiesk 2014) which are specific to certain
disease-causing pathogens, and this can occur without sero-
conversion post vaccination. Consequently, when the calf
receives a secondary vaccination after the MDA have declined,
production of high levels of antibody consistent with a memory
response occurs.
Marker vaccines are commercially available, inactivated or
live-attenuated (Kaashoek et al. 1994, 1995) and for bovine her-
pesvirus type 1 (BoHV-1) the gene coding for the unnecessary
glycoprotein E (gE) has been deleted. This allows for serological
differentiation between vaccinated animals and animals that
have had natural contact with the microorganism (seropositivity
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does not necessarily imply infection) (Van Oirschot et al. 1997).
This is a useful method to detect infected animals and eliminate
them from the herd to prevent the possibility of reactivation of
latent virus (Ackermann et al. 1990, Kaashoek et al. 1995).
Weaning is often a very stressful time for calves due to the
alteration of several environmental and social husbandry prac-
tices, such as changing their diet in which they receive no milk,
and usually calves are re-housed with different animals at
weaning which they are unfamiliar with, and this can lead to
social stress. The separation from the dam and termination
of milk feeding do not occur simultaneously in the dairy calf
(Flower and Weary 2003). Dairy calves are normally removed
from their dams at birth and fed milk and concentrate by arti-
ficial means thereafter. Therefore, weaning of dairy calves
solely involves the removal of milk from their diets (Flower
and Weary 2003). Artificially reared dairy calves are typically
weaned from milk either abruptly, or gradually. Gradual
weaning is preferable to abrupt weaning (Khan et al. 2007,
Jasper et al. 2008, Nielsen et al. 2008, Sweeney et al. 2010,
Lorenz, Mee, et al. 2011, Hill et al. 2012, De Passillé and
Rushen 2016).
Abrupt weaning of artificially reared dairy calves has led to
increased vocalization, activity, cross-suckling and unrewarded
occupancy at a milk feeder (Budzynska and Weary 2008,
Nielsen et al. 2008), whereas gradual weaning has increased
both starter consumption and feed efficiency and improved
rumen function and average daily gain (ADG) (Khan et al.
2007, Sweeney et al. 2010, Hill et al. 2012, De Passillé and
Rushen 2016). Acute phase proteins (APPs) are often used as
an indicator of infection, inflammation, surgical trauma or
stress-related illness. Haptoglobin is an important APP in the
bovine species. It reduces pro-oxidative and pro-inflammatory
stress by means of binding haemoglobin and removing it
from the animal’s circulation (Murata et al. 2004).
The objectives of this study were (1) to examine the effect of
divergent immune status on the response to bovine respiratory
syncytial virus (BRSV) vaccination at 3 weeks of age; (2) to trace
the transfer of gE-negative BoHV-1 antibodies from vaccinated
dams to calf sera and investigate how passive immunity affects
response to live infectious bovine rhinotracheitis (IBRV) vaccine
at 6 weeks of age; and (3) to explore the effect of passive trans-
fer status on blood metabolites pre and post weaning. The
hypothesis of the study was that calves receiving a lower
volume (5% body weight (BW)) of colostrum, thus possessing
less MDA than calves fed 10% BW would respond better to
BRSV and IBRV vaccination, and that there would be no effect
of passive transfer immune status on blood metabolite concen-
tration around weaning.
Methods and materials
All procedures and treatments within this study were con-
ducted under the UK Animal (Scientific Procedures) Act
(Office, 1986). This study was conducted at AFBI research
dairy farm in Hillsborough, located in County Down, in Northern
Ireland (latitude 52°27′, longitude 6°4′). The study population
consisted of 37 multiparous Holstein cows, which received
their annual vaccinations in October and calved between 9 Feb-
ruary and 17 April 2014 and 37 dairy bred calves.
Dam vaccination
All cows involved in this study were immunized against BoHV-1
(gE) in October 2013 (4-month prior to start of calving); they
were injected intra-muscularly with a commercial vaccine
(Bovilis IBRV Marker Inactivated, MSD Animal Health, Buckin-
ghamshire, England).
Management of calves
The experiment involved two first feed maternal colostrum
treatments in which the calves were fed according to their
BW at birth: (1) 5% of BW of colostrum at birth (5 BW) and (2)
10% of BW of colostrum at birth (10 BW). The birth of each
calf was vigilantly observed and calves were separated from
their dam approximately 15–20 min post parturition to
prevent suckling occurring. Calves were weighed and placed
in a straw-bedded pen where they were blood sampled and
received their first feed of colostrum, according to the colos-
trum treatment group to which they were assigned (5% BW
versus 10% BW). Calves were randomly assigned to colostrum
treatment group depending on calf gender, and fed their
own dams colostrum via oesophageal tube within 2.5 hours
post birth. Nine males were allocated to each group and 7
and 12 females were allocated to 5 BW and 10 BW groups,
respectively. Calves in 5 BW and 10 BW groups averaged 39.8
and 40.8 kg, respectively. For the first colostrum feed, the two
groups received 5% and 10% of their body weight of first
milking colostrum for 5 BW and 10 BW treatments, respectively.
Subsequently, the calves in 5 BW treatment were fed 5% of their
BW of second milking colostrum (from their own dam) 12 hours
post calving via a teat feeder. Whereas the calves in 10 BW
group received colostrum from the first milking post birth
(stored at 4°C and heated to body temperature before
feeding). Following the first and second colostrum feeds, all
calves were fed 12.5% of their BW of colostrum from their
own dam for the first 4 days of life. Calves were individually
penned for the first 4 days of life, and on day 5 were placed
in a group pen where they were fed ‘Calf Gold milk replacer
(MR)’ (Britmilk, Dumfries, UK) from an automatic milk feeder
(Forster Technik vario, Germany). Calves were gradually
weaned (day 56) by the step-down method. All calves were
offered ad libitum concentrate and clean water from 5 days
of age. Disbudding of calves took place at approximately 5–6
weeks of age. Post weaning calves were removed from their
original pen to another group pen on day 63 and fed grass
silage plus 2 kg concentrate per day until 70 days of age
when the experiment was complete.
Calf vaccination
All calves in the study were immunized at 3 weeks of age
against Parainfluenza type 3 virus (PI3 virus), BRSV andMannhei-
mia (Pasteurella) haemolytica serotype A1 via subcutaneous
injection using a commercial vaccine called Bovipast RSP
(MSD Animal Health, Buckinghamshire, UK), a booster was
then administered 4 weeks later. All calves were also immu-
nized against BoHV-1 at 6 weeks of age, using one dose of a
live commercial vaccine (Bovilis IBR marker, MSD Animal
Health, Buckinghamshire, UK); this was administered via intra-
nasal route at 6 weeks of age.
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Blood sample collection
Blood samples were collected from the tail vein of cows using a
10 mL serum vacutainer (BD, Oxford, UK) at weeks −5, −3, −1
pre calving and +2 post calving. Blood samples were collected
from the calf via the jugular vein using a 10 mL serum vacutai-
ner tube (BD, Oxford, UK), at 0, 24, 48 and 72 hours post birth
and days 7, 14, 21, 35, 49, 56 and 70 post birth. All blood
samples were left at room temperature for 1 hour to allow clot-
ting to occur; samples were then centrifuged at 1764×g for 15
min, serum was decanted into three aliquots and stored at
−20°C until specific antibody analysis.
Additional blood samples were collected from the calf via
the jugular vein using a 10 mL serum vacutainer tube (BD,
Oxford, UK) pre and post weaning on days 49, 53, 56, 57 and
day 60. All blood samples were left at room temperature for 1
hour to allow clotting to occur. Samples were then centrifuged
at 1764×g for 15 min, serum was decanted into three aliquots
and stored at −20°C until blood metabolite analysis.
Sample analysis
Bovine herpesvirus 1 (gE) antibody. Bovine herpesvirus 1 gE
antibody was analysed using an ELISA kit for BoHV-1 gE anti-
body from IDEXX (Hoofddorp, The Netherlands). All kit reagents
were brought to 18–26°C and mixed gently through inverting
and swirling, and test procedure was followed according to
manufacturer’s instructions. The OD values were recorded
using a microplate spectrophotometer with a 650 nm filter.
Samples were assayed in duplicate, with an inter-assay CV <
0.15. The concentration of BoHV-1 (gE) antibody was calculated
by dividing the absorbance of the sample by the mean absor-
bance of the negative control which resulted in an S/N value.
The quantity of antibodies to gE was inversely proportional to
the absorbance and the S/N value. If the S/N value was less
than or equal to 0.60, the sample was classified as positive for
antibodies to the gE antigen of BoHV-1. If the S/N was greater
than 0.70, the sample was classified as negative for antibodies
to the gE antigen of BoHV-1. Any samples that were greater
than 0.60 but less than or equal to 0.70 were retested.
Infectious bovine rhinotracheitis and respiratory syncytial
virus antibody. IBRV and BRSV were analysed using indirect
ELISA kits from Svanova (Uppsala, Sweden). All kit reagents
were brought to 18–26°C and the test procedure was followed
according to manufacturer’s instructions. The OD values were
recorded using a microplate spectrophotometer with a
450 nm filter. Samples were assayed in duplicate, with an
inter-assay CV of 0.15. The corrected OD value for controls
and serum samples were calculated by subtracting the OD
values of the corresponding wells containing the control
antigen. The percentage positivity values were also calculated
by dividing the corrected OD value of the sample or negative
control by the corrected OD value of the positive control and
multiplying by 100.
Blood metabolites. Serum non-esterified fatty acids, beta-
hydroxybutyrate (BHBA), haptoblobulin (Hp) and urea concen-
trations were analysed using the Audit Sapphire 800 Analyser
(Audit Diagnostics, Cork, Ireland).
Statistical analysis
Statistical analyses were performed using GenStat, 16th edition
(VSN International, 2015). Statistical differences were considered
significant at P < .05. REML linear mixed models were performed
to detect significant differences among experimental groups.
Pre-vaccination antibody titre and day of vaccination were used
as covariates and colostrum treatment groups were fitted as
fixed effects. Blood metabolites were analysed using repeated
measures; colostrum treatment group was fitted as a fixed effect.
Results
The number of weeks relative to parturition had an effect
(P = .03) on the mean concentration of antibodies to the gE
antigen of BoHV-1 in the dam’s blood (Figure 1). The number
of weeks relative to parturition had no effect (P >.05) on the
total IBRV antibody concentration (Figure 2).
Peak levels of maternally derived total IBRV antibody were
recorded in the calves’ sera during the first 2 days post birth
subsequent to colostrum consumption, and the MDA specific
to IBRV showed a gradual decline thereafter (Figure 3). Colos-
trum treatment had no significant effect on the percentage
positivity of both antibodies to IBRV and BRSV. However, time
did have a significant effect on percentage positivity of anti-
bodies to total IBR (P = .001) and BRSV (P < .001). Total anti-
bodies to IBR peaked at 48 h post birth and decreased
thereafter, whereas BRSV antibodies also peaked at 48 hours,
decreasing until day 49 and then started to increase.
Overall, 24.3% and 37.8% of calves were treated for pneumo-
nia in the neonatal period and 28–70 days period, respectively,
whereas 37.8% of calves were treated for diarrhoea in the neo-
natal period and 0% of calves were treated in the 28–70 days
period.
The colostrum feeding regime (5% versus 10% BW) had no
effect (P > .05) on the mean concentration of antibodies to
the gE antigen of BoHV-1 circulating in the calves sera from
birth to 70 days of age (Figure 4). Both treatment groups
tested negative to gE antibody (Figure 4).
We observed that during the time of primary vaccination
against BRSV at 3 weeks of age there was no increase in anti-
body titre to the agent circulating in the vaccine in the calves’
Figure 1. ELISA ratio (±SEM) measurements assessing the presence or absence of
gE antibody pre and post parturition. A value above 0.7 indicates animals are nega-
tive for the presence of circulating gE-specific antibodies.
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sera. We found no significant difference between colostrum
treatments or incline in antibodies post primary vaccine at
day 21 (P = .35) (Figure 5).
We found no difference (P > .05) between colostrum treat-
ment groups in terms of response to vaccine at 35, 49, 56 and
70 days post birth. The number of days post vaccination had
a significant effect on the level of circulating BRSV in the
calves’ sera independent of treatment group (P < .001); we
observed BRSV antibody titre to be significantly greater at
days 56 and 70 than at days 35 and 49 (Figure 6).
Colostrum treatment had no effect (P > .05) on BHBA, non-
esterified fatty acids (NEFA), urea and Hp concentration in the
calves’ blood pre, during and post weaning. However, we
found the age of calf to have an effect (P < .05) on these blood
metabolites. The BHBA concentration was lowest pre-weaning
and increased at weaning and thereafter, whereas NEFA concen-
tration decreased at weaning and thereafter. We observed the
urea and Hp levels to be greatest in the days post weaning
(Table 1). We found no difference (P > .05) between treatment
group and calf feeding behaviour, that is, visits to the feeder
without reward of milk replacer (MR) (Figure 7).
However, the number of visits to the feeder without reward of
MR peaked for both treatment groups at approximately day 55 (4
days post weaning). The step-down weaning method decreasing
MR volume offered and consumed from day 35 with a direct
increase in the amount of concentrate consumed (Figure 8).
Discussion
A newborn calf passively receives MDA via their dam’s colostrum
and these are critical in the neonatal immune response (Niewiesk
2014). Vaccination of the young calf is often practised in an effort
to provide additional protection from common disease-causing
pathogens during the first few months of life, as the immune
system matures and MDA decay (Chase et al. 2008). This study
was performed to determine whether the colostrum feeding
volume had any effect on their response to BRSV and BoHV-1
(IBRV) vaccination in the early weeks of life, and the effects of
passive transfer on blood metabolites at weaning.
Neonatal immune response (birth to 28 days)
It has been well documented that calves that receive adequate
volumes of good quality colostrum shortly after birth achieve
adequate passive transfer (APT) in terms of their serum IgG
Figure 3. Mean (±SEM) level of maternal total antibody to IBR circulating in the
calves’ blood post parturition.
Figure 2. Mean total antibody concentration to IBR circulating in dam’s blood pre
and post parturition.
Figure 5. Mean (±SEM) total IBR antibodies circulating in calves’ blood post birth
when fed 5 or 10% of BW in colostrum at first feed.
Figure 4. Mean (±SEM) ratio of IBR gE antibody circulating in the calves’ blood
post calving when fed 5 or 10% of their BW in colostrum at first feed. Arrow indi-
cates time of vaccine administration at 42 days of age. A value above 0.7 indicates
animals are negative for the presence of circulating gE-specific antibodies.
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concentration post feeding. However, a study by Chamorro
et al. (2014) confirmed calves with adequate IgG concentration
to be still highly vulnerable to specific respiratory viruses, such
as BRSV and BoHV-1. It has been suggested that this may be due
to the differences in maternal colostrum sources, dam vacci-
nation history, natural exposure to infection and levels of
specific viral antibodies in the colostrum (Chamorro et al.
2014). A study by Munoz-Zanzi et al. (2002) reported that the
duration of passively transferred immunity to respiratory dis-
eases was associated with the concentration of antibodies
during the first 3 days of life. Therefore, the greater is the anti-
body concentration, the longer time it takes for MDA to decay.
This was not apparent in our study as we observed no differ-
ences between treatment groups of calves which showed
different levels of passive transfer. This may be due to the
high quality and timely manner in which calves were fed colos-
trum at their first feed. Many of the calves in the 5 BW group
achieved APT, and therefore at 3 weeks of age it is likely that
not all of the MDA had decayed.
The majority of vaccinated dams involved in this study
tested negative for antibodies to the gE antigen of BoHV-1
during the dry period. Similarly, reports from Van Oirschot
et al. (1997) demonstrated that sera from cattle that were vac-
cinated with a gE-negative marker vaccine scored negative.
Van Oirschot et al. (1997) reported that cattle naturally
exposed to BoHV-1 tested positive for antibodies to the gE
antigen of BoHV-1 in the gE ELISA. In addition to this, animals
that received an initial vaccination and were then challenged
with infection, thus having reduced virus replication, also
became gE seropositive. As a result of vaccinating the dam
with a marker vaccine in this current study, the antibodies
were then traceable in the calves’ blood post colostrum
intake and calves also scored negative to the gE antibody.
This demonstrated the transfer of the BoHV-1 specific
Figure 6. Mean (±SD) BRSV antibody circulating in calf sera post birth. Solid arrow
indicates time of primary vaccination (day 14) and dashed arrow indicates time
(day 42) of booster vaccination with a multivalent respiratory vaccine.
Figure 7. Effect of days on feeder on the number of visits to the feeder without reward of milk replacer (MR). Dashed arrows indicate time point where milk is stepped
down and solid arrow indicates time of weaning.




Days relative to weaning (d 0)
SEDd
P-value
5 BW 10 BW −7 −3 0 1 2 4 8 Ta Day(D) D × T
BHBAb 0.21 0.22 0.01 0.16 0.19 0.22 0.22 0.24 0.21 0.27 0.02 0.62 <0.001 0.38
NEFAc 0.14 0.13 0.008 0.17 0.15 0.13 0.15 0.13 0.10 0.11 0.02 0.33 <0.001 0.30
Urea 2.68 3.02 0.31 2.66 2.75 2.84 2.77 2.64 2.75 3.52 0.22 0.18 0.01 0.17
Haptoglobin 0.35 0.35 0.01 0.28 0.32 0.38 0.38 0.41 0.34 0.32 0.02 0.66 0.02 0.54
aTreatments: 5 or 10% of BW in colostrum at first feed.
bBeta hydroxybutyrate.
cNon-esterified fatty acids.
dStandard error of the difference (SED).
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antibodies from vaccination to the calves and consequently it
could be verified that this came from the marker vaccine
given to the dam as the calves were also gE-negative when
tested by ELISA.
Our findings demonstrated the majority of cows to have
total IBRV antibodies circulating in their blood. When the
dams were tested using the ELISA method to detect gE anti-
bodies, it was confirmed that the presence of IBRV antibodies
in the dams was the result of vaccination and not wild-type
infection as all of the animals were gE-negative. Consequently,
we found calves to have a considerable level of total IBRV anti-
bodies circulating in their blood post colostral feeding as a
result of MDA. In contrast to the current study, research
carried out in Ireland during 2009 to estimate dairy and beef
herd seroprevalence of BoHV-1 found a high seroprevalence
of 74.9% wild-type IBRV (95% C.I. 69.9–79.8%). A small percen-
tage of herds (2%) within the study vaccinated the dams
against BoHV-1, which indicates that natural infection in wide-
spread (Cowley et al. 2011).
At the time of the primary BRSV vaccination we observed
that there was no increase in antibody titre to the agent circu-
lating in the vaccine in the calves’ blood. This may be due to the
presence and interference of MDA from colostrum and the
immaturity of the immune system (Tyler et al. 1989). In parallel
to this study, Windeyer et al. (2015) investigated the relation-
ship of BRD or artificial immunization with the serologic
response in Holstein calves; findings confirmed that the time
taken for the anti-BRSV antibody to decay was longer in
calves that were treated for BRD than in those that were not.
Reports showed that timing of vaccination had no effect on
the rate of antibody decay when immunized at 2 or 5 weeks
of age, and that using a multivalent respiratory vaccine on
calves with APT was not beneficial to the calf, due to the level
of MDA present.
Immune response (4 weeks to 10 weeks)
A large proportion of calves (37.8%) were treated for pneumonia
during the 4–10 weeks period post parturition, and the rate of
pneumonia was much greater compared to that during the neo-
natal period in this current study. This is similar to reports from
Van Donkersgoed et al. (1993), and is probably due to the
window of vulnerability between MDA decline and immaturity
at this time. However, when calves are challenged at a later
date by this specific pathogen or given a booster vaccination,
the calf is already primed from the primary vaccine. Although
post primary vaccination did not result in an increase in antibody
titre levels in the blood, it is likely that a cell-mediated response
may have occurred post vaccination (Fulton et al. 2004). Conse-
quently, after the booster vaccine (2 weeks later) the calf had an
improved ability to produce increased antibody levels in the
blood (which is known as an amnestic response to the infection,
Woolums, 2014) and demonstrated there was immune priming
following the first dose of vaccine.
Van Donkersgoed et al. (1995) reported on the effects of
various vaccination protocols on passive and active immunity
to Pasteurella haemolytica and Haemophilus somnus in beef
calves. The authors established that calves vaccinated at 3
and 4 months of age, when there were still low levels of pre-
existing antibodies circulating, had significantly greater anti-
body titres to P. haemolytica at 5 months of age and to
H. somnus at 5 and 6 months of age than calves that were
not vaccinated. It has been suggested by Woolums (2007)
that vaccinating calves when MDA are still present may be of
benefit to the producer in terms of cost and animal welfare;
calves are very vulnerable to disease at this young age and vac-
cines can be very effective in producing a protective immune
response to later pathogen challenge. In some cases calves
are not fully protected when vaccinated in the face of maternal
antibodies and this is thought to be correlated with the age of
the animal at vaccination, type of vaccination, amount of MDA
in circulation and virulence of the challenging pathogen
(Woolums, 2007).
BRSV is a challenging issue in calves as MDA are often
present in 1- to 6-month-old calves. This can have a knock on
effect on vaccination programmes because these antibodies
do not decay until approximately 40 days of age (van der
Poel et al. 1999, Chase et al. 2008). Our results mirror this
issue, where there was no response to vaccination at 3 weeks
of age after the primary vaccination.
Reports from Lemaire et al. (2001) showed the ability of a
BoHV-1 gE-negative vaccine strain to establish latency in both
seronegative and calves that received passive immunity sub-
sequent to a single intranasal immunization. However, the effi-
cacy of the gE-negative vaccine was reduced in calves which
Figure 8. Effect of days on feeder on concentrate intake between colostrum treatment groups. Dashed arrow indicates the first step-down phase in MR and solid arrow
indicates time of weaning (transition from liquid to solid diet).
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received MDA. Vaccination cannot prevent latency of the vaccine
itself or natural exposure to wild-type BoHV-1, therefore it is
crucial that producers have a vaccination plan where immuniz-
ation is repeated according to the protocol and other manage-
ment factors are in place to encourage eradication of this disease.
Weaning is often a stressful event for young calves (Schaefer
et al. 1997) as demonstrated by visible physiological changes in
their health, performance and well-being. There is a strong
association with stress and growth, fertility, animal welfare,
carcass quality and vulnerability to disease (Schaefer et al.
1997, Ali et al. 2008). In this current study, we found the colos-
trum treatment group (5% versus 10% BW) to have no effect
on the blood metabolite concentrations measured during the
weaning period. We believe that this is because calves were all
fed identical diets after their second colostrum feed, and there-
fore the difference in colostrum treatment was too slight to
cause a difference between treatment groups at weaning time.
At the time of weaning, it is likely that the MDA have declined
and the calves immune system has somewhat matured since
birth and become more independent in terms of producing
endogenous Ig. We observed no difference (P > .05) in immune
status after 3 days of age as a result of colostrum feeding
within the present study. In addition to this, these calves were
gradually weaned using a step-down method and still had
access to the milk feeding equipment where they could suckle
the artificial teat. The advantage of gradual weaning is that it pre-
pares the calf for weaning through reducing the volume of milk
fed and thus creates a greater demand for nutrients. Conse-
quently, the calf consumes an increased amount of solid feed
during the step-down phase, and this reduces the likelihood of
growth lag during the post weaning period (Khan et al. 2007,
Sweeney et al. 2010). These findings are similar to reports from
Jasper et al. (2008) where calves that were offered continued
access to the milk feeding system and provided with warm
water instead of milk had reduced acute response to weaning
compared to abruptly weaned calves; abruptly weaned calves
were more active and vocalizations were observed at more
than 3 times the rate. There have been previous suggestions
that other factors besides the withdrawal of milk at weaning
can be distressing for dairy calves, such as not being able to
suckle the milk feeding equipment (Jasper et al. 2008). The
calves in the present study had access to the milk feeding equip-
ment for a minimum of 1 week post weaning. Hill et al. (2012)
reported that calves gradually weaned over a 2- to 3-week
period that had been fed 0.88 kg DM of MR did not cause any
reduction in starter consumption and ADG (Hill, et al. 2012). In
addition to this, Sweeney et al. (2010) reported a gradual
reduction in the volume of milk fed over a 10-day period to be
the best step-downmethod in terms of weight gain performance
for calves weaned at 56 days of age.
In the current study, the age of the calf did have an effect on
the metabolite concentration levels. In comparison to this,
Lynch et al. (2010) found no effects (P > .05) of treatment or
treatment × day interactions for serum Hp concentrations
when calves were weaned abruptly. However, day of sampling
was significant (P = .0002) for Hp in this study, and on day 2 the
Hp concentration increased compared with baseline (0.48 mg/
mL versus 0.32 mg/mL). In this study, BHBA levels increased
post weaning and this finding is comparable to reports from
Klotz and Heitmann (2006) and Khan et al. (2011) where
BHBA levels increased as the calf got older. This was an indi-
cation of change in sources of physiological fuel at the time
of weaning when there was a shift from liquid milk to a solid
diet. Quigley and Bernard (1992) suggested that this increase
in BHBA may be a result of increased solid feed intake and
reflect a response to alimentary ketogenesis. In contrast to
BHBA concentration, NEFA concentration circulating in calves’
blood decreased at weaning and thereafter. This finding is in
agreement with Klotz and Heitmann (2006) who reported a
large decline in NEFA concentration between week 5 and
week 8, 0.27 and 0.16 mmol/L, respectively. Similar to the
current study, the decline in NEFA coincided with the termin-
ation of MR at weaning (week 7). Quigley (1996) reported a
negative correlation between NEFA concentration and the
intake of starter concentrate in the pre-ruminant calf. It has
been suggested that this is due to the change in diet compo-
sition in terms of the transition from a liquid diet which is
high in fat and lower in carbohydrate to a solid diet lower in
fat and higher in carbohydrate (Klotz and Heitmann 2006). It
has been reported that Hp concentrations increase quickly
during inflammatory distress (Conner et al. 1988). The Hp con-
centration in the calves’ blood appeared to increase at
weaning and peak at 2 days post weaning, decreasing to
normal levels thereafter. This indicates that the removal of
milk from the diet at weaning had a stressful impact on the
calves, which results in an inflammatory response.
Conclusion
The mean level of antibodies to the gE antigen of BoHV-1
during the dry period tested negative due to the presence of
artificial infection via gE-negative marker vaccine. As expected
the MDA for the specific respiratory viruses were at their peak
levels in the calves sera post colostrum ingestion and decreased
thereafter. There were no differences between colostrum treat-
ment groups on the level of BRSV antibodies post vaccination at
3 weeks of age and post booster vaccination 4 weeks later. Anti-
bodies to the gE antigen of BoHV-1 tested negative within both
treatment groups as a result of pre-parturient immunization.
Colostrum treatment group had no significant effect on the
levels of stress during the weaning period, in terms of the
blood metabolites analysed within this study. Gradual
weaning is recommended to minimize the level of stress
caused to the calf and allows for a smooth transition from
liquid to solid diet. Further research is required in this field to
investigate appropriate timing of vaccination regimes to maxi-
mize immune response during the neonatal period to reduce
the level of BRD within dairy herds.
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